EPIRUS Biopharmaceuticals, Inc. Finite-lived Intangible Assets Acquired
EPIRUS Biopharmaceuticals, Inc. reported Finite-lived Intangible Assets Acquired of -$1.25 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-31.
Discontinued › Notes › Goodwill and Other
us-gaap:FinitelivedIntangibleAssetsAcquired1 · last filed 2015-03-31
- EPIRUS Biopharmaceuticals, Inc. finite-lived intangible assets acquired for fiscal 2014 was -$1.25M.
| Period end | Finite-lived Intangible Assets Acquired 12 month |
|---|---|
| 2014-12-31 | -$1.25M 10-K · filed 2015-03-31 |